≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Maze procedure for atrial fibrillation

Endpoint Browser

AF_MAZE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Operations: NOMESCO codes — ^FPD00

1 out of 7 registries used, show all original rules.

154

4. Check minimum number of events

None

154

5. Include endpoints

None

154

6. Filter based on genotype QC (FinnGen only)

154

Control definitions (FinnGen only)

Control exclude
AF_OPER

Extra metadata

First used in FinnGen datafreeze
DF4

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 154 50 104
Unadjusted period prevalence (%) 0.04 0.02 0.05
Median age at first event (years) 64.51 67.24 63.20

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
140
Matched controls
1400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
FPD00
NOMESCO Finland
Maze procedure for atrial fibrillation
+∞
202.3
140
*
B01AA03
ATC
warfarin; systemic
114.3
84.5
134
228
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
72.5
82.2
94
38
I34.1
ICD-10 Finland
Mitral (valve) prolapse
138.1
81.5
82
14
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
51.7
77.9
99
62
I48
ICD-10 Finland
Atrial fibrillation and flutter
79.6
75.2
133
269
TFP20
NOMESCO Finland
Cardiodefibrillation
34.2
65.3
93
76
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
267.0
64.0
61
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
24.5
59.0
112
196
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
82.6
58.9
64
14
WX872
NOMESCO Finland
Intensive care
33.5
54.5
74
45
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
21.2
53.2
116
259
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
86.7
50.0
54
10
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
56.3
43.9
51
14
C07AB07
ATC
bisoprolol; oral
35.1
42.6
134
544
ZXE30
NOMESCO Finland
More than five and less than seven hours
31.3
41.5
56
29
C01BD01
ATC
amiodarone; systemic
29.5
39.4
54
29
207
Kela drug reimbursment
Chronic arrhythmias
12.7
39.1
87
160
FKC50
NOMESCO Finland
Repair of mitral valve for insufficiency using prosthetic chord
258.1
38.9
38
*
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
26.6
38.8
55
33
AC4
HP
MVP
486.3
37.9
36
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
11.5
36.8
87
174
R4110
NOMESCO Finland
Physiotherapy
10.4
35.3
100
270
Z2221
NOMESCO Finland
Medical doctor
9.9
33.9
94
239
AH3
HP
Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery
+∞
33.7
31
*
ZXE20
NOMESCO Finland
More than three and less than five hours
10.2
30.7
72
131
ZXD10
NOMESCO Finland
Scheduled procedure
7.7
27.0
105
391
I34.01
ICD-10 Finland
Mitral (valve) regurgitation NOS or of specified cause, except rheumatic
90.5
27.0
29
*
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
301.6
25.6
25
*
C03CA01
ATC
furosemide; systemic
7.0
25.4
93
308
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.1
25.2
116
522
FFM30
NOMESCO Finland
Occlusion of atrial appendage internally by internal suture ligation
+∞
24.7
23
*
WX408
NOMESCO Finland
General anesthesy, balanced
6.8
24.6
87
271
C01AA05
ATC
digoxin; systemic
11.0
24.3
50
67
XF400
NOMESCO Finland
ECG with 12 standard connections
7.3
23.7
70
168
FKC60
NOMESCO Finland
Resection and reconstruction of leaflet of mitral valve for insufficiency
100.7
23.5
25
*
Z3226
NOMESCO Finland
Physiotherapist
7.4
23.4
68
159
XF404
NOMESCO Finland
Ambulatory ECG
8.3
22.0
55
101
ZXE00
NOMESCO Finland
One hour or less
5.9
21.2
97
389
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
6.6
21.0
66
167
WX404
NOMESCO Finland
Intravenous generell anesthesy
6.5
21.0
67
173
K78
ICPC
Atrial fibrillation/flutter
9.2
20.7
47
73
I50.9
ICD-10 Finland
Heart failure, unspecified
6.9
20.3
59
133
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
47.7
20.2
24
6
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
23.0
19.6
28
15
AN1
HP
Coronary angiography
6.3
18.4
57
137
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
204.9
18.0
18
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.6
17.4
40
62
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.8
17.2
58
153
C07AA07
ATC
sotalol; systemic
12.4
16.5
30
30
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
5.5
16.2
56
150
AH2
HP
Treatment of atrial fibrillation by maze surgery or its modification as the only procedure
+∞
15.9
15
*
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
9.2
15.7
34
47
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
51.2
15.5
18
*
Z3231
NOMESCO Finland
Registered nurse
4.5
15.2
73
273
ZXD05
NOMESCO Finland
Urgent procedure
4.4
15.0
76
298
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
6.3
14.8
43
92
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
48.0
14.5
17
*
C03DA01
ATC
spironolactone; oral
5.8
14.0
44
103
TPH04
NOMESCO Finland
Cathetrisation of vein
4.6
13.9
58
186
PD5BD
NOMESCO Finland
Extensive CT of aorta
14.3
13.2
22
18
C01BC04
ATC
flecainide; systemic
10.6
12.9
25
28
AP3
HP
Catheterization of the right and left side of the heart
35.8
12.9
16
5
B01AB05
ATC
enoxaparin; parenteral
3.8
12.3
75
329
FFM10
NOMESCO Finland
Occlusion or excision of atrial appendage externally with a closing device
+∞
11.6
11
*
AD1
HP
TVP
130.3
11.6
12
*
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
6.8
11.6
30
54
I50.0
ICD-10 Finland
Congestive heart failure
6.0
11.5
33
68
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
65.1
10.8
12
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.5
10.3
32
72
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.9
10.2
20
23
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
10.0
76
376
B01AF02
ATC
apixaban; oral
4.8
9.9
35
91
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.5
9.9
56
223
WX892
NOMESCO Finland
Monitored bed care
5.5
9.9
30
66
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
8.3
9.7
21
29
FKC20
NOMESCO Finland
Plastic repair of mitral valve leaflet for insufficiency
107.0
9.5
10
*
AC2
HP
MVR bio
+∞
9.5
9
*
C09AA05
ATC
ramipril; oral
3.2
9.4
65
295
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.7
9.3
27
56
K83
ICPC
Heart valve disease NOS
20.3
9.1
13
7
WZC30
NOMESCO Finland
Teaching
3.7
8.9
43
149
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.9
8.9
25
50
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.3
8.8
23
42
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
6.9
8.6
21
35
201
Kela drug reimbursment
Chronic cardiac insufficiency
6.9
8.6
21
35
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
+∞
8.4
8
*
FKC96
NOMESCO Finland
Other repair of mitral valve for insufficiency
+∞
8.4
8
*
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
8.4
8
*
XF620
NOMESCO Finland
Examination of circulation with color method
35.6
8.2
10
*
XF402
NOMESCO Finland
ECG with work load test
3.7
8.2
38
127
WX402
NOMESCO Finland
General anaesthesia
3.6
8.1
40
141
I47.1
ICD-10 Finland
Supraventricular tachycardia
7.9
7.8
17
24
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
26.7
7.7
10
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
21.4
7.2
10
5
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
21.4
7.2
10
5
N02BE01
ATC
paracetamol; systemic, rectal
4.5
7.1
130
1037
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
8.3
7.1
15
20
AA1
HP
Conventional CABG
7.4
7.1
16
24
I49.5
ICD-10 Finland
Sick sinus syndrome
6.1
6.9
18
33
I50.1
ICD-10 Finland
Left ventricular failure
6.1
6.9
18
33
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.1
6.6
20
44
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
5.1
6.6
20
44
TFP32
NOMESCO Finland
Cathetric treatmen of cardiac arrythmia
73.0
6.5
7
*
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
5.4
6.3
18
37
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
28.1
6.3
8
*
C01BA03
ATC
disopyramide; systemic
28.1
6.3
8
*
FKC10
NOMESCO Finland
Suture of cleft mitral leaflet
+∞
6.3
6
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.5
6.1
21
53
K84
ICPC
Heart disease other
7.8
6.1
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
82
134
11.95
54.65
2.6
2.9
ug/l
29.1
9.1
3.70
82
116
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
71
101
12.19
52.46
2.7
3.6
ng/l
317.7
273.3
0.27
66
92
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
102
314
7.66
35.15
2.6
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
48
10.54
30.96
4.3
1.8
u/ml
0.3
0.3
0.59
23
26
(3000991) Gas panel - Venous blood
59
122
7.22
29.89
13.8
7.6
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
30
33
11.05
25.61
2.3
2.0
%
204.6
198.2
0.11
30
33
(3032080) INR in Blood by Coagulation assay
126
587
7.31
24.55
25.3
8.9
inr
2.2
1.3
4.32
17
179
(3044640) Blood type and Crossmatch panel - Blood
105
430
5.53
23.51
3.0
2.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
72
225
5.13
22.34
3.9
3.5
mmol/l
0.8
0.8
0.72
67
213
(3024928) Oxygen saturation in Venous blood
21
25
9.57
16.67
3.3
2.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
20
10.70
16.45
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
20
10.70
16.45
1.6
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
113
618
4.11
14.41
3.5
4.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
134
828
5.76
14.40
9.2
4.6
mmol/l
6.5
6.9
1.38
129
784
(3019230) Fractional oxyhemoglobin in Venous blood
19
26
8.20
13.44
3.3
2.1
%
57.1
66.3
0.63
19
26
(3002032) Base excess in Venous blood by calculation
43
130
4.20
13.10
3.4
4.3
mmol/l
1.7
1.8
0.06
37
99
(3012544) pH of Venous blood
43
132
4.13
12.81
3.5
4.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
50
176
3.73
12.21
15.1
6.9
mmol/l
-0.2
1.0
1.52
42
145
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
32
81
4.72
12.19
20.2
7.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
74
336
3.31
12.06
6.3
6.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
56
214
3.54
12.05
3.6
3.0
e6/l
0.7
1.7
0.86
24
116
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
59
238
3.40
11.60
3.3
2.7
e6/l
0.8
1.1
0.63
27
139
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
29
6.90
11.00
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
43
5.50
10.12
7.8
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
73
377
2.78
8.83
4.6
2.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
101
627
2.77
8.33
11.4
5.8
mmol/l
1.2
1.2
1.48
95
561
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
65
324
2.74
8.32
2.8
2.0
mg/l
2.9
3.3
0.72
57
283
(3044889) 12 lead EKG panel
131
952
3.52
7.77
9.0
4.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
73
400
2.57
7.56
4.6
3.0
e6/l
0.4
0.4
0.02
50
305
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
27
5.60
7.11
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40
168
2.87
6.94
1.8
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
136
1037
3.66
6.90
9.2
7.9
u/l
77.2
79.8
0.34
131
971
(3002582) Erythrocytes [#/volume] in Urine
75
432
2.43
6.80
4.6
3.2
e6/l
23.4
229.8
0.78
51
337
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
165
2.83
6.66
1.8
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
81
490
2.38
6.50
5.4
3.7
e6/l
10.3
75.6
2.33
54
363
(3011648) Oxygen content in Venous blood
10
15
7.06
6.39
2.0
1.8
%
9.8
11.7
—
10
15
(3011397) Hemoglobin [Presence] in Urine by Test strip
56
290
2.46
6.33
2.7
3.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
91
587
2.35
6.19
7.0
10.9
e9/l
0.0
0.0
0.59
67
488
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
74
3.48
6.19
1.6
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
80
493
2.30
6.01
3.1
2.6
ug/l
142.3
167.4
0.53
74
453
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
100
678
2.35
5.97
11.4
7.0
mmol/l
1.2
1.2
2.46
93
565
(3001604) Monocytes [#/volume] in Blood
96
641
2.32
5.93
6.8
6.0
e9/l
0.6
0.6
0.39
77
552
(3006315) Basophils [#/volume] in Blood
96
642
2.32
5.89
6.9
6.0
e9/l
0.0
0.0
0.73
77
554
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
82
515
2.27
5.84
4.9
3.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
15
430
0.28
5.78
1.9
3.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
72
430
2.27
5.77
6.0
5.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
11
376
0.24
5.73
1.5
3.6
—
—
—
0
0
(3000492) Spirometry study
30
119
2.89
5.71
1.7
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
97
659
2.28
5.63
7.1
6.2
e9/l
0.2
0.2
0.01
80
581
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
110
2.89
5.42
2.7
2.6
ml/min/173m2
63.5
61.1
—
8
50
(3019198) Lymphocytes [#/volume] in Blood
96
657
2.22
5.37
6.9
6.0
e9/l
1.7
1.9
0.45
79
581
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
23
82
3.12
5.25
3.4
2.8
%
1.5
1.3
0.19
23
82
(3013650) Neutrophils [#/volume] in Blood by Automated count
106
760
2.27
5.22
8.4
9.8
e9/l
4.3
4.3
0.01
84
666
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
53
293
2.23
4.99
2.2
1.7
mg/l
1.5
1.6
0.10
44
236
(3023368) Bacteria identified in Blood by Culture
67
412
2.11
4.78
6.5
4.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
43
228
2.23
4.42
2.0
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
27
526
0.41
4.39
3.2
4.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
79
539
1.96
4.05
2.3
2.0
pmol/l
95.5
92.5
0.28
42
279
(3042936) Bacteria identified in Isolate by Culture
40
214
2.17
3.99
2.6
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
143
1232
3.25
3.81
33.0
15.0
ml/min/173m2
75.6
77.3
0.44
133
1020
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
137
1160
2.64
3.68
6.8
4.4
mu/l
2.0
2.0
0.14
127
1025
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
116
922
2.05
3.61
5.2
3.6
pmol/l
15.5
15.0
1.01
106
806
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
9
8.08
3.59
1.3
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
9
8.08
3.59
1.0
1.8
u/l
14.0
12.4
—
7
9
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
9
8.08
3.59
1.3
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
52
318
1.96
3.59
3.3
2.5
e6/l
6.1
3.4
0.63
43
274
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
82
2.65
3.55
1.2
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
42
3.29
3.46
1.6
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
18
5.24
3.42
1.0
1.1
—
—
—
0
0
(3013512) EKG study
23
439
0.44
3.35
5.3
4.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
38
3.34
3.29
1.8
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
132
1116
2.28
3.27
47.1
16.3
%
38.2
39.9
2.60
117
744
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
144
1270
3.06
3.18
31.1
15.9
mg/l
36.1
25.5
3.19
133
1042
(3031040) Bacteria [#/volume] in Urine by Automated count
107
845
1.87
3.17
6.0
4.5
—
457.5
—
0
16
(3007853) Bacteria identified in Skin by Aerobe culture
31
164
2.11
3.14
2.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
81
2.54
3.13
1.9
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
43
259
1.92
3.05
3.6
3.0
mmol/l
2.5
2.5
0.33
33
232
(3028308) Erythrocytes [#/volume] in Pleural fluid
7
13
5.58
2.90
3.7
1.2
e6/l
4411.0
43511.9
—
7
8
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
6
10
6.19
2.72
1.3
1.3
u/l
6.3
6.5
—
6
10
(3026782) Osmolality of Urine
46
295
1.80
2.65
3.9
2.8
mosm/kgh2o
540.9
575.0
0.72
34
248
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
11
5.62
2.57
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
11
5.62
2.57
3.7
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
13
51
2.69
2.51
1.3
1.7
g/l
35.4
37.7
0.89
13
45
(3034770) Mitochondria Ab [Titer] in Serum
10
34
3.08
2.46
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
11
40
2.88
2.43
1.1
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
40
2.88
2.43
1.1
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
8
6.41
2.39
1.4
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
41
2.81
2.33
2.1
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
7
177
0.37
2.21
4.1
4.9
%
36.6
31.6
—
7
111
(3015377) Calcium [Moles/volume] in Serum or Plasma
60
434
1.63
2.18
3.3
3.3
mmol/l
2.4
2.3
0.33
50
379
(3003694) ABO and Rh group [Type] in Blood
49
338
1.66
2.13
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
90
2.13
2.10
1.8
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
20
3.61
2.08
2.1
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
15
4.12
2.06
3.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
64
2.31
2.01
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
53
382
1.59
1.91
3.3
3.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
59
2.31
1.90
1.3
1.7
g/l
13.2
10.2
0.76
13
52
(3020891) Body temperature
14
66
2.23
1.88
5.2
4.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
40
2.60
1.87
1.1
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
53
2.37
1.86
1.1
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
5
12
4.27
1.83
2.6
1.3
u/l
155.3
129.3
—
5
12
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
139
1266
2.01
1.81
4.5
5.0
mmol/l
6.0
6.1
0.44
130
1137
(3043409) Potassium [Moles/volume] in Arterial blood
12
54
2.33
1.79
4.8
3.5
mmol/l
4.1
4.0
0.27
12
49
(3020564) Creatinine [Moles/volume] in Serum or Plasma
146
1366
2.32
1.71
41.5
19.0
umol/l
90.1
82.9
1.43
146
1366
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
19
3.24
1.68
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
22
129
1.82
1.67
1.5
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
63
2.16
1.65
1.3
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
63
2.16
1.65
1.3
1.7
g/l
7.1
7.6
0.22
13
50
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
63
2.16
1.65
1.3
1.7
g/l
4.2
3.7
0.52
13
48
(3019225) pH of Specimen
6
140
0.41
1.62
1.8
4.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
11
50
2.29
1.61
1.2
3.3
mg/l
40.6
31.2
0.40
11
40
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
11
50
2.29
1.61
1.2
3.3
—
3.0
—
0
8
(3034860) Kappa light chains.free [Mass/volume] in Serum
11
50
2.29
1.61
1.2
3.3
mg/l
221.1
50.6
0.49
11
40
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
163
1.72
1.59
1.4
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
25
155
1.73
1.59
1.4
1.3
titre
384.0
340.0
—
5
40
(3028026) IgM [Mass/volume] in Serum or Plasma
16
86
1.96
1.57
1.4
1.6
g/l
1.0
1.3
0.83
16
78
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
132
1.78
1.56
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
136
1244
1.80
1.54
4.2
4.3
mmol/l
1.1
1.3
2.82
129
1120
(1761482) Bacteria [#/volume] in Urine by Culture
0
44
0.00
1.54
0.0
5.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
27
2.67
1.53
1.7
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
35
240
1.59
1.53
1.3
1.4
g/l
2.7
2.9
0.15
21
146
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
21
2.93
1.52
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
138
1272
1.82
1.46
4.6
4.8
mmol/l
1.3
1.4
1.32
131
1149
(40761511) CBC panel - Blood by Automated count
143
1334
2.01
1.43
28.0
14.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
23
2.67
1.38
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
17
3.00
1.37
1.0
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
0
37
0.00
1.36
0.0
2.4
—
7.9
—
0
32
(3007461) Platelets [#/volume] in Blood
148
1409
2.29
1.36
46.6
23.0
e9/l
213.1
239.5
7.77
142
1372
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
72
587
1.43
1.35
5.2
4.1
ng/l
23.0
44.9
1.69
56
443
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
24
2.56
1.31
1.5
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
18
2.83
1.29
1.0
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
44
331
1.46
1.26
1.9
1.6
nmol/l
14.9
20.1
2.05
37
278
(3037756) Immunofixation for Serum or Plasma
8
37
2.22
1.23
1.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
37
2.22
1.23
1.0
3.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
148
1411
2.25
1.23
46.6
23.0
e12/l
4.3
4.5
6.64
142
1372
(3010813) Leukocytes [#/volume] in Blood
148
1411
2.25
1.23
46.6
23.1
e9/l
6.8
6.8
0.02
142
1371
(3019060) Gas panel - Arterial blood
18
110
1.72
1.22
4.5
4.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
110
978
1.44
1.21
4.1
4.2
mm/h
14.4
12.6
0.55
105
892
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
26
2.36
1.20
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
33
0.00
1.17
0.0
2.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
39
2.11
1.17
1.0
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
140
0.48
1.16
1.7
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
0
36
0.00
1.15
0.0
2.7
—
2.3
—
0
21
(3005719) IgG [Mass/volume] in Serum or Plasma
17
104
1.71
1.15
1.8
2.0
g/l
14.1
10.3
0.70
17
92
(3000494) Fungus identified in Specimen by Culture
25
170
1.56
1.14
1.7
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
140
1313
1.73
1.14
5.6
5.4
mmol/l
2.5
2.7
0.92
134
1189
(4094501)
7
31
2.32
1.12
1.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
5
21
2.43
1.10
1.6
1.4
—
97.4
—
0
7
(4034850)
9
48
1.93
1.02
27.6
14.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
35
2.05
1.01
2.1
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
20
133
1.58
1.00
3.9
2.6
e9/l
66.2
69.7
—
9
103
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
51
410
1.36
0.99
2.8
3.1
ug/l
0.7
0.8
0.55
37
271
(3021901) Oxygen saturation in Capillary blood
0
29
0.00
0.99
0.0
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
36
1.99
0.98
1.0
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
31
0.00
0.97
0.0
2.7
—
16.3
—
0
16
(3026493) Urate [Moles/volume] in Serum or Plasma
48
383
1.37
0.97
2.7
2.9
umol/l
7216.1
10756.6
0.19
42
321
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
51
1.81
0.96
1.4
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
70
1.77
0.95
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
29
2.11
0.90
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
23
163
1.48
0.88
1.3
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
133
1249
1.48
0.87
5.3
6.3
mmol/mol
39.0
40.9
2.25
124
1150
(40760892) CBC W Ordered Manual Differential panel - Blood
21
287
0.69
0.81
3.1
5.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
98
0.49
0.81
1.4
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
24
0.00
0.80
0.0
3.5
—
63.8
—
0
24
(3035285) Chloride [Moles/volume] in Venous blood
0
27
0.00
0.78
0.0
3.2
—
106.3
—
0
27
(3041354) Potassium [Moles/volume] in Venous blood
0
27
0.00
0.78
0.0
3.2
—
4.0
—
0
27
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
27
0.00
0.78
0.0
3.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
27
0.00
0.78
0.0
4.3
—
0.9
—
0
20
(3037467) Urinalysis macro (dipstick) panel - Urine
97
884
1.26
0.68
5.1
4.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
95
1.52
0.67
1.2
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
28
1.81
0.66
1.4
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
30
1.69
0.62
1.2
1.2
u/l
32.6
12.0
—
5
25
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
21
0.00
0.60
0.0
3.5
—
40.0
—
0
5
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
21
0.00
0.60
0.0
4.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
64
1.60
0.60
5.8
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
59
514
1.24
0.60
1.9
2.3
nmol/l
84.1
78.3
0.63
50
449
(3042631) Mycobacterium sp identified in Specimen
0
22
0.00
0.60
0.0
4.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
23
0.00
0.59
0.0
2.7
—
5.3
—
0
23
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
15
204
0.71
0.57
1.8
1.2
iu/ml
39.2
45.5
—
6
68
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
55
1.48
0.57
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
37
1.65
0.56
2.2
1.5
—
—
—
0
0
(4010399)
14
100
1.44
0.54
1.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
10
141
0.69
0.47
1.8
2.1
nmol/l
9.9
13.3
—
10
133
(3019832) Treponema pallidum Ab [Presence] in Serum
7
50
1.42
0.45
1.0
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
56
500
1.19
0.43
2.2
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
32
1.58
0.42
1.0
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
114
1.35
0.42
1.6
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
2.2
—
478.9
—
0
7
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
16
0.00
0.41
0.0
2.8
—
33.3
—
0
16
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
34
1.49
0.40
1.6
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
18
0.00
0.40
0.0
2.9
—
57.2
—
0
11
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
1.4
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
19
0.00
0.39
0.0
1.9
—
90.3
—
0
19
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
180
1.26
0.38
15.5
8.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
65
708
0.86
0.38
4.5
5.1
ug/l
2.2
2.7
0.33
58
631
(3009508) Creatinine [Moles/volume] in Urine
47
420
1.17
0.35
2.5
3.3
mmol/l
6.8
7.8
0.88
41
345
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
83
1.35
0.33
1.4
1.2
—
18.9
—
0
5
(3008152) Bicarbonate [Moles/volume] in Arterial blood
13
101
1.31
0.33
8.9
7.3
mmol/l
22.7
24.2
1.00
13
95
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
89
839
1.14
0.32
3.3
3.2
u/l
93.2
54.8
1.43
83
785
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
75
0.66
0.26
1.6
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
159
0.80
0.26
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
71
669
1.11
0.23
2.3
2.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
40
1.26
0.22
1.4
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
41
1.23
0.22
1.4
1.7
—
—
—
0
0
(4035726)
15
126
1.21
0.22
1.1
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
42
1.20
0.21
1.0
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
42
1.20
0.21
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
0
11
0.00
0.21
0.0
9.1
—
7.4
—
0
5
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
0
11
0.00
0.21
0.0
1.9
—
499.2
—
0
6
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
17.5
—
0
10
(3014271) Vancomycin [Susceptibility]
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
12
0.00
0.21
0.0
4.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
48
1.26
0.20
1.7
2.2
mg/l
2.1
1.6
—
6
42
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
55.5
—
0
6
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
44
410
1.10
0.17
2.6
3.3
mg/l
41.4
59.7
0.58
34
278
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
66
0.75
0.17
1.2
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
120
1.18
0.17
4.9
3.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
80
1.13
0.15
1.0
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
59
565
1.07
0.12
4.5
4.6
%
25.1
21.0
1.10
25
282
(1002224) Polysomnography panel
6
53
1.14
0.09
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
62
0.80
0.08
1.0
4.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
120
0.91
0.05
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
45
439
1.04
0.03
3.0
4.1
mg/mmol
7.0
8.2
0.19
30
292
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
158
0.94
0.02
2.9
3.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
29
287
1.01
0.00
1.9
1.7
nmol/l
840.7
1260.7
2.50
21
219
(40768797) Stomach Pathology biopsy report
18
178
1.01
0.00
1.0
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
6.8
—
39.2
—
0
6
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
32.5
—
0
6
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
10.2
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
56
0.89
0.00
1.0
1.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
2.3
—
14.3
—
0
6
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
101.5
—
0
6
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
74
0.94
0.00
1.3
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
8.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
1.9
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
19.7
—
0
8
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
150.0
—
0
7
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
15.0
—
1562.7
—
0
7
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
73
0.96
0.00
2.7
2.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
10.1
—
944.7
—
0
7
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
1.0
—
0
9
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
1.1
—
0
5
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
11.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
32.0
—
0
5
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
61
0.98
0.00
1.0
2.9
u/ml
7.0
3225.9
—
6
47
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
9.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.1
—
9.5
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AF_MAZE – Maze procedure for atrial fibrillation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).